Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B

Gastroenterology. 1981 Dec;81(6):987-91.

Abstract

Hepatitis B virus associated DNA polymerase activity, hepatitis b surface antigen (HBsAg), and serum aspartate aminotransferase were followed in 21 patients with chronic active hepatitis while immunosuppressive therapy (prednisone +/- azathioprine) was being withdrawn. In every case, DNA polymerase activity fell within 6-10 wk of decreasing treatment and became undetectable in 8 patients. This was usually accompanied by a fall in HbsAg titer and a transient rise in serum aspartate aminotransferase activity. Four additional patients with previously untreated HbsAg positive chronic active hepatitis were placed on prednisone for 12 wk. There was a rise in DNA polymerase activity and HBsAg titer with a fall in serum aspartate aminotransferase values during treatment. Upon discontinuing therapy, DNa polymerase activity fell dramatically in all 3 patients who completed their course of prednisone and became undetectable in 1. These findings suggest that immunosuppressive therapy has a potentiating effect on hepatitis B viral replication in patients with chronic active hepatitis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aspartate Aminotransferases / blood*
  • Azathioprine / therapeutic use
  • Chronic Disease
  • DNA-Directed DNA Polymerase / blood*
  • Female
  • Hepatitis B / blood
  • Hepatitis B / drug therapy*
  • Hepatitis B / immunology
  • Hepatitis B Surface Antigens / analysis*
  • Hepatitis B virus / enzymology
  • Hepatitis B virus / immunology
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Middle Aged
  • Prednisone / therapeutic use

Substances

  • Hepatitis B Surface Antigens
  • Immunosuppressive Agents
  • Aspartate Aminotransferases
  • DNA-Directed DNA Polymerase
  • Azathioprine
  • Prednisone